For continuation versus noncontinuation, the weighted prevalence ratios were 1.29 (95 percent confidence interval, 0.82 to 2.06), 1.08 (95 percent confidence interval, 0.84 to 1.40), and 1.21 (95 percent confidence interval, 0.83 to 1.82) for small for gestational age, large for gestational age, and MCM, respectively."Accumulated evidence provides some reassurance about risk for malformations after inadvertent exposure in women who become pregnant while using GLP-1 RAs," the authors write.Abstract/Full Text (subscription or payment may be required).Sign up for our weekly HealthDay newsletter
If youre struggling to lose weight with your semaglutide prescription or want to kickstart a journey with it, our experienced team at Rojas Regenerative Institute can help
Weight regain after stopping is common
ENHANZE Drug Delivery Technology: Inspiring New Possibilities
Understanding that financial barriers should never stand in the way of good health, the clinic collaborates with a wide range of insurance providers to cover consultations, FDA-approved medications, nutritional counseling, behavioral therapy, and follow-up appointments